02/18/2026
Join our sibiling study today or share with your network!
The CircaMS study is investigating circadian rhythmicity as a biomarker for symptomatic phenotypes in MS. All adults (+18) living with MS who experience daily fatigue and/or pain are eligible to participate.
Click this link: https://circams.ca/ to join the study today or share with your network!
MS Canada National Multiple Sclerosis Society
The CircaMS study is investigating circadian rhythmicity as a biomarker for symptomatic phenotypes in MS. All adults (+18) living with MS who experience daily fatigue and/or pain are eligible to participate.
Click this link: https://circams.ca/ to join our study today!
This study has been reviewed and received ethics clearance through the Queen’s University Research Ethics Board.